Stocktoria
ROCKWELL MEDICAL, INC. RMTI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1998-01-27
ROCKWELL MEDICAL, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $69.3M | $101.5M | $83.6M | $72.8M | $61.9M |
| Gross profit | $11.7M | $17.5M | $8.7M | $4.1M | -$2.4M |
| R&D expense | $0 | $19,000 | $1.1M | — | — |
| Operating income | -$4.7M | $608,000 | -$6.7M | -$16.8M | -$30.3M |
| Interest expense | — | — | $2.3M | $1.9M | $2.4M |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$5.3M | -$480,000 | -$8.4M | -$18.7M | -$32.7M |
| EPS (diluted) | $-0.15 | $-0.03 | $-0.37 | $-1.31 | $-3.83 |
| Operating cash flow | -$659,000 | $4.2M | -$9.4M | -$16.9M | -$33.5M |
| Cash & equivalents | $10.7M | $15.7M | $9.0M | $10.1M | $13.3M |
| Inventory | $3.4M | $5.8M | $5.9M | $5.8M | $4.1M |
| Total assets | $57.1M | $59.2M | $52.2M | $46.6M | $48.6M |
| Total liabilities | $20.2M | $26.6M | $30.9M | $32.5M | $46.0M |
| Shareholders' equity | $37.0M | $32.6M | $21.3M | $14.1M | $2.5M |
Source: SEC EDGAR filings · CIK 0001041024 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.